Inactive Instrument

Rise Life Science Corp Stock Toronto S.E.

MOM

CA55028M1032

Latest news: Rise Life Science Corp

12/11/21	Britannia Bud Canada Holdings Inc. completed the acquisition of RISE Life Science Corp. in a reverse merger transaction.	CI
02/11/21	RISE Life Science Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2021	CI
30/10/21	Scientus Pharma Inc. cancelled the acquisition of RISE Life Science Corp. in a reverse merger transaction.	CI
01/09/21	RISE Life Science Corp. Appoints Greg Taylor as Board of Director	CI
30/07/21	RISE Life Science Corp. Reports Earnings Results for the Second Quarter Ended May 31, 2021	CI
29/04/21	Rise Life Science Corp. Reports Earnings Results for the First Quarter Ended February 28, 2021	CI
15/04/21	RISE Life Science Corp. announced that it has received $1.331 million in funding	CI
30/03/21	Rise Life Science Corp. Reports Earnings Results for the Full Year Ended November 30, 2020	CI
04/03/21	RISE Life Science Corp. announced that it expects to receive $0.71 million in funding	CI
22/01/21	Britannia Bud Canada Holdings Inc. entered into a Letter of intent to acquire RISE Life Science Corp. in a reverse merger transaction.	CI
31/10/20	Rise Life Science Corp. Reports Earnings Results for the Third Quarter Ended August 31, 2020	CI
29/07/20	Rise Life Science Corp. Reports Earnings Results for the Second Quarter Ended May 31, 2020	CI
13/04/20	RISE Life Science Corp. announced that it expects to receive CAD 10 million in funding	CI

More news

Press Releases: Rise Life Science Corp

18/11/21	IIROC Trade Resumption - BLAB	AQ
15/11/21	Britannia Completes "Go Public" Transaction via Reverse Takeover of Rise Life Sciences and Launches Britannia Life Sciences Inc.	AQ
02/09/21	RISE Life Science : Greg Taylor Joins the Board of RISE Life Science Corp.	AQ
11/06/21	RISE Life Science Corp :. Announces Conversion of Debentures and Debt Settlement	AQ
03/05/21	Britannia Enters into Definitive Agreement with Rise Life Science to "Go Public" via Reverse Takeover of Rise Life Science	NE

More press releases

Special Foods & Wellbeing Products

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
RISE LIFE SCIENCE CORP	+11.11%	+59.09%	-	-	9.68M
NESTLÉ S.A.	+0.33%	+1.76%	+8.86%	-13.79%	270B
MONDELEZ INTERNATIONAL, INC.	+0.64%	+0.09%	+16.19%	-3.63%	84.1B
DANONE	+0.80%	+2.42%	-13.48%	+17.92%	48.76B
THE HERSHEY COMPANY	-2.58%	+1.30%	+1.68%	-8.03%	34.87B
ARCHER-DANIELS-MIDLAND COMPANY	-0.19%	-7.83%	+22.57%	-3.22%	33.24B
FOSHAN HAITIAN FLAVOURING AND FOOD COMPANY LTD.	-1.45%	+0.17%	-7.14%	-8.44%	30.28B
INNER MONGOLIA YILI INDUSTRIAL GROUP CO., LTD.	-0.99%	+1.70%	+14.11%	+12.70%	29.51B
KRAFT HEINZ	-0.77%	-2.05%	+0.58%	-25.89%	28.91B
NESTLÉ INDIA LIMITED	+1.49%	+8.89%	+2.94%	+7.15%	26.7B
Average	+0.84%	+0.91%	+5.15%	-2.80%	65B
Weighted average by Cap.	+0.05%	+1.34%	+7.16%	-6.78%

See all sector performances

Britannia Life Sciences Inc, formerly RISE Life Science Corp, is a Canada-based vertically diversified product development company. The Company's platform provides an integrated, one-stop shop service for product development, testing, safety & compliance and consumer evaluations/trials. Its principal activities include quality ingredients, formulations, safety assessment, analytical & quality assessments, global compliance and regulation, consumer trials and evaluations for various sectors. It serves Consumer packaged goods (CPG), cosmetics, household goods and nutraceutical industries, blue-chip, food and beverage, nutraceutical sectors, toiletries, small and medium enterprise (SME) clients.

Employees

Sector

Food Processing

More about the company